Viperin, through its radical-SAM activity, depletes cellular nucleotide pools and interferes with mitochondrial metabolism to inhibit viral replication

FEBS Lett. 2020 May;594(10):1624-1630. doi: 10.1002/1873-3468.13761. Epub 2020 Mar 2.

Abstract

Viperin (RSAD2) is an antiviral radical S-adenosylmethionine (SAM) enzyme highly expressed in different cell types upon viral infection. Recently, it has been reported that the radical-SAM activity of viperin transforms cytidine triphosphate (CTP) to its analogue 3'-deoxy-3',4'-didehydro-CTP (ddhCTP). Based on biochemical studies and cell biological experiments, it was concluded that ddhCTP and its nucleoside form ddhC do not affect the cellular concentration of nucleotide triphosphates and that ddhCTP acts as replication chain terminator. However, our re-evaluation of the reported data and new results indicate that ddhCTP is not an effective viral chain terminator but depletes cellular nucleotide pools and interferes with mitochondrial activity to inhibit viral replication. Our analysis is consistent with a unifying view of the antiviral and radical-SAM activities of viperin.

Keywords: NTPs; RSAD2; antiviral; chain termination; ddhCTP; metabolism; mitochondria; radical-SAM; unifying view; viperin.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antiviral Agents / metabolism
  • Antiviral Agents / pharmacology
  • Cell Respiration
  • Cytidine Triphosphate / metabolism
  • Cytidine Triphosphate / pharmacology
  • Humans
  • Inhibitory Concentration 50
  • Mitochondria / drug effects
  • Mitochondria / metabolism*
  • Nucleotides / metabolism*
  • Nucleotides / pharmacology
  • Oxidoreductases Acting on CH-CH Group Donors
  • Proteins / metabolism*
  • Uridine Triphosphate / metabolism
  • Virus Replication* / drug effects

Substances

  • 3'-deoxy-3',4'-didehydro-CTP
  • Antiviral Agents
  • Nucleotides
  • Proteins
  • Cytidine Triphosphate
  • Oxidoreductases Acting on CH-CH Group Donors
  • RSAD2 protein, human
  • Uridine Triphosphate